FIORINAL W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fiorinal W, and when can generic versions of Fiorinal W launch?
Fiorinal W is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in FIORINAL W is aspirin; butalbital; caffeine; codeine phosphate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FIORINAL W?
- What are the global sales for FIORINAL W?
- What is Average Wholesale Price for FIORINAL W?
Summary for FIORINAL W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for FIORINAL W |
| DailyMed Link: | FIORINAL W at DailyMed |
US Patents and Regulatory Information for FIORINAL W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | FIORINAL W/CODEINE | aspirin; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 019429-003 | Oct 26, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
